Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invitris
Planegg-Martinsried, Bavaria, Germanyinvitris.com ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Preclinical
01
Overview
Invitris has developed a universal cell-free protein expression platform that enables rapid design and scalable production of synthetic proteins—including bacteriophages—to address antimicrobial resistance. Their technology allows the creation of novel therapeutic modalities with unique mechanisms of action. The company has demonstrated proof-of-concept in assembling phage-based drugs but has not yet reported clinical trial results. They have received multiple awards for innovation and entrepreneurship.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Synthetic proteinsBacteriophages (phages)EndolysinsTailocinsNeoantigensVaccinesAntibodies
- Industry
- Biotech
02
Partnerships
Collaborates with biopharmaceutical companies to integrate its platform into their pipelines; specific partners not named publicly.
Beyond the preview
Go deeper on Invitris.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Invitris.